On the other hand, adding too much bulk to a system that is already moving slowly can make things worse, not better
The results are inconclusive, but there are some promising results so far: In one small study with just 12 (healthy middle-aged non-smoker) subjects (taking either 500 or 1,000 mg per day liposomal glutathione for four weeks), there was a trend for increasing glutathione levels, although it only became significant in the 500 mg dose after two weeks, which was also the largest increase at 25%
Second-generation: cilofexor (GS-9674), tropifexor (LJN452) Cilofexor is a potent, selective, nonsteroidal agonist of FXR that predominantly activates intestinal FXR without involvement of the enterohepatic circulation
However, as the current associations are descriptive and not based on correlation or causal inference, prospective randomized studies with formal correlation analyses, extended follow-up, and broader hormonal profiling are essential to validate these observations and guide individualized treatment approaches